Lataa...

Immune checkpoint inhibitors in genitourinary malignancies

Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Oncol
Päätekijät: Thana, M., Wood, L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Multimed Inc. 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/
https://ncbi.nlm.nih.gov/pubmed/32368176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!